IL17A and breast cancer: Analysis of lung Vγ4+ and Vγ6+ cells in mammary tumor-conditioned lungs revealed that inhibition of ICOS, PD-1, or TIM-3 failed to alter the proportion of cells expressing IL-17A, IL-17F, TIM-3, or AREG.